Sun Pharmaceutical Industries Profile
Key Indicators
- Authorised Capital ₹ 600.00 Cr
as on 28-10-2024
- Paid Up Capital ₹ 239.93 Cr
as on 28-10-2024
- Company Age 31 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.06 Cr
as on 28-10-2024
- Satisfied Charges ₹ 1,785.22 Cr
as on 28-10-2024
- Revenue -1.66%
(FY 2024)
- Profit 69.05%
(FY 2024)
- Ebitda -13.68%
(FY 2024)
- Net Worth -0.23%
(FY 2024)
- Total Assets 0.19%
(FY 2024)
About Sun Pharmaceutical Industries
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524715 and on the National Stock Exchange(NSE) under SUNPHARMA.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 600.00 Cr and a paid-up capital of Rs 239.93 Cr.
The company currently has active open charges totaling ₹16.06 Cr. The company has closed loans amounting to ₹1,785.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sun Pharmaceutical Industries Limited India are Chinnadharavaram Muralidharan as CFO and Anoop Deshpande as Company Secretary. Rama Bijapurkar, Gautam Doshi, Sudhir Valia, and Five other members serve as directors at the Company.
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sun Pharmaceutical Industries Limited offer?
Sun Pharmaceutical Industries Limited offers a wide range of products and services, including Vitamins & Supplements, Mineral Supplements, Health Conditions, Respiratory Care, Women Care, Mother Care, Pain Relief, Skin Care, Bath Essentials, Specialty Supplements.
Who are the key members and board of directors at Sun Pharmaceutical Industries?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anoop Deshpande | Company Secretary | 31-Jan-2022 | Current |
Dilip Shanghvi | Managing Director | 01-Apr-2008 | Current |
Chinnadharavaram Muralidharan | CFO | 19-Jun-2017 | Current |
Board Members(7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjay Asher | Director | 01-Nov-2022 | Current |
Rama Bijapurkar | Director | 21-May-2021 | Current |
Gautam Doshi | Director | 25-May-2018 | Current |
Sudhir Valia | Director | 31-Jan-1994 | Current |
Pawan Goenka | Director | 21-May-2021 | Current |
Aalok Shanghvi | Whole-Time Director | 01-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Sun Pharmaceutical Industries.
Sun Pharmaceutical Industries Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 1.66% decrease. The company also saw a substantial improvement in profitability, with a 69.05% increase in profit. The company's net worth dipped by a decrease of 0.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sun Pharmaceutical Industries?
In 2024, Sun Pharmaceutical Industries had a promoter holding of 54.47% and a public holding of 45.53%. The company had 14 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sun Pharma Laboratories Limited
Active 27 years 10 monthsGautam Doshi, Sudhir Valia and 1 more are mutual person
Shantilal Shanghvi Foundation
Active 20 years 6 monthsSudhir Valia and Dilip Shanghvi are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Nvfc Finance Private Ltd Creation Date: 26 May 1999 | ₹7.50 M | Open |
Risk Capital And Technology Finance Corporation Ltd Creation Date: 29 Apr 1999 | ₹1.50 Cr | Open |
Industrial Development Bank Of India Creation Date: 17 Nov 1998 | ₹3.25 Cr | Open |
How Many Employees Work at Sun Pharmaceutical Industries?
Sun Pharmaceutical Industries has a workforce of 19552 employees as of Oct 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharmaceutical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.